"Science" article from Johanna Olweus's group highlighted by editorial in New England Journal of Medicine
The article "Targeting of cancer neoantigens with donor-derived T cell receptor repertoires" by Erlend Strønen et al, published in Science in June 2016, is highlighted by an editorial in the "Clinical Implications of Basic Research" section in the Feb 2nd edition of New England Journal of Medicine.
The editorial is entitled "The Antigenicity of the Tumor Cell — Context Matters".
The CCB seminar Tuesday January 31st will be held by Baldur Sveinbjørnsson from Lytix Biopharma, Oslo Cancer Cluster.
Title of his talk: Oncolytic peptide LTX-315; the road from basic science to clinical trials
Time and place: Tuesday January 31st of at 12:00 hrs in the Auditorium in the Research Building, Institute for Cancer Research, Montebello.
Refreshments are served in the lobby after the seminar
The Norwegian Radium Hospital Research Foundation will also for 2017 distribute resources to photodynamic therapy and photochemical internalization (PDT/PCI) related research. In 2016 various research projects within this field were founded with a total of NOK 1,79 million. Employees at the Oslo University Hospital are welcome to apply.
The closing date for applications is February 28th, 2017.
Findings from Rusten group published in Nature on microenvironmental autophagy draw nationwide attention
Nadja Katheder and collaborators in the lab of Tor Erik Rusten, the Department of Molecular Cell Biology, and CCB has published an article entitled "Microenvironmental autophagy supports tumor growth", in an advanced online publication 11th of January in the journal Nature (journal impact factor 41.46).
The findings have been subject to news coverage by the Norwegian national broadcasting corporation (NRK).
The prestigious journal "Developmental Cell" has recently published an article in their "Previews" section, entitled "Breaking Down Neighbors to Fuel Tumorigenesis". Here, the authors discuss how the work of Katheder and colleagues "opens new avenues for understanding and manipulating cancers through cell-cell communication."
The Norsk Hydro’s Fund for Cancer Research Lecture January 16th 10:45 - 12:00 in the Auditorium (K-building) at Montebello will be held by the prominent scientist Channing J. Der from UNC Lineberger Comprehensive Cancer Center, Chapel Hill.
Title of his talk:
"Drugging undruggable RAS for cancer treatment"
Dr. Channing J. Der is recognized internationally for his contribution to the discovery and research of the Ras family of oncoproteins.